These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 37209301)

  • 21. Established and novel measures of upper limb impairment in children with Charcot-Marie-tooth disease type 1A and riboflavin transporter deficiency type 2.
    Cornett KMD; Menezes MP; Bray P; Halaki M; Burns J
    J Peripher Nerv Syst; 2018 Mar; 23(1):29-35. PubMed ID: 29168276
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peripheral nerve ultrasound in pediatric Charcot-Marie-Tooth disease type 1A.
    Yiu EM; Brockley CR; Lee KJ; Carroll K; de Valle K; Kennedy R; Rao P; Delatycki MB; Ryan MM
    Neurology; 2015 Feb; 84(6):569-74. PubMed ID: 25576636
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biomarkers predict outcome in Charcot-Marie-Tooth disease 1A.
    Fledrich R; Mannil M; Leha A; Ehbrecht C; Solari A; Pelayo-Negro AL; Berciano J; Schlotter-Weigel B; Schnizer TJ; Prukop T; Garcia-Angarita N; Czesnik D; Haberlová J; Mazanec R; Paulus W; Beissbarth T; Walter MC; Triaal C; Hogrel JY; Dubourg O; Schenone A; Baets J; De Jonghe P; Shy ME; Horvath R; Pareyson D; Seeman P; Young P; Sereda MW
    J Neurol Neurosurg Psychiatry; 2017 Nov; 88(11):941-952. PubMed ID: 28860329
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes in walking velocity and stride parameters with age in children with Charcot-Marie-Tooth disease.
    Õunpuu S; Pierz KA; Acsadi G; Wren TAL
    Neuromuscul Disord; 2020 Oct; 30(10):825-832. PubMed ID: 32928646
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo confocal microscopy of Meissner corpuscles as a novel sensory measure in CMT1A.
    Almodovar JL; Ferguson M; McDermott MP; Lewis RA; Shy ME; Herrmann DN
    J Peripher Nerv Syst; 2011 Sep; 16(3):169-74. PubMed ID: 22003930
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recombination hot spot in a 3.2-kb region of the Charcot-Marie-Tooth type 1A repeat sequences: new tools for molecular diagnosis of hereditary neuropathy with liability to pressure palsies and of Charcot-Marie-Tooth type 1A. French CMT Collaborative Research Group.
    Lopes J; LeGuern E; Gouider R; Tardieu S; Abbas N; Birouk N; Gugenheim M; Bouche P; Agid Y; Brice A
    Am J Hum Genet; 1996 Jun; 58(6):1223-30. PubMed ID: 8651299
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Foot Function Index: A Promising Questionnaire for Individuals With Charcot-Marie-Tooth Disease Type 1A.
    Bihel L; Reynaud V; Givron P; Clavelou P; Cornut-Chauvinc C; Pereira B; Thomas E; Taithe F; Coudeyre E
    Arch Phys Med Rehabil; 2019 Dec; 100(12):2403-2406. PubMed ID: 31255638
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ascorbic acid in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL and CMT-TRAUK): a double-blind randomised trial.
    Pareyson D; Reilly MM; Schenone A; Fabrizi GM; Cavallaro T; Santoro L; Vita G; Quattrone A; Padua L; Gemignani F; Visioli F; Laurà M; Radice D; Calabrese D; Hughes RA; Solari A; ;
    Lancet Neurol; 2011 Apr; 10(4):320-8. PubMed ID: 21393063
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coexistence of Charcot Marie Tooth disease type 1A and diabetes in Taiwan: A clinicopathological study.
    Chao HC; Chou CT; Lee YC; Lin KP
    J Neurol Sci; 2015 Nov; 358(1-2):213-20. PubMed ID: 26349404
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Psychoacoustics and neurophysiological auditory processing in patients with Charcot-Marie-Tooth disease types 1A and 2A.
    Choi JE; Seol HY; Seok JM; Hong SH; Choi BO; Moon IJ
    Eur J Neurol; 2020 Oct; 27(10):2079-2088. PubMed ID: 32478888
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Soluble Neuregulin1 is strongly up-regulated in the rat model of Charcot-Marie-Tooth 1A disease.
    Fornasari BE; Ronchi G; Pascal D; Visigalli D; Capodivento G; Nobbio L; Perroteau I; Schenone A; Geuna S; Gambarotta G
    Exp Biol Med (Maywood); 2018 Feb; 243(4):370-374. PubMed ID: 29350067
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of comorbidities on the phenotype of patients affected by Charcot-Marie-Tooth neuropathy type 1A.
    Ursino G; Alberti MA; Grandis M; Reni L; Pareyson D; Bellone E; Gemelli C; Sabatelli M; Pisciotta C; Luigetti M; Santoro L; Massollo L; Schenone A
    Neuromuscul Disord; 2013 Nov; 23(11):902-6. PubMed ID: 23891256
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNAs as Biomarkers of Charcot-Marie-Tooth Disease Type 1A.
    Wang H; Davison M; Wang K; Xia TH; Call KM; Luo J; Wu X; Zuccarino R; Bacha A; Bai Y; Gutmann L; Feely SME; Grider T; Rossor AM; Reilly MM; Shy ME; Svaren J
    Neurology; 2021 Aug; 97(5):e489-e500. PubMed ID: 34031204
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of focal mechanic vibration treatment on balance in Charcot-Marie-Tooth 1A disease: a pilot study.
    Pazzaglia C; Camerota F; Germanotta M; Di Sipio E; Celletti C; Padua L
    J Neurol; 2016 Jul; 263(7):1434-41. PubMed ID: 27177999
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The impact of symptoms on daily life as perceived by patients with Charcot-Marie-Tooth type 1A disease.
    Tozza S; Bruzzese D; Severi D; Spina E; Iodice R; Ruggiero L; Dubbioso R; Iovino A; Aruta F; Nolano M; Santoro L; Manganelli F
    Neurol Sci; 2022 Jan; 43(1):559-563. PubMed ID: 33899151
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Validation of the Italian version of the Charcot-Marie-Tooth Health Index.
    Pisciotta C; Ciafaloni E; Zuccarino R; Calabrese D; Saveri P; Fenu S; Tramacere I; Genovese F; Dilek N; Johnson NE; Heatwole C; Herrmann DN; Pareyson D;
    J Peripher Nerv Syst; 2020 Sep; 25(3):292-296. PubMed ID: 32511835
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma metabolome and skin proteins in Charcot-Marie-Tooth 1A patients.
    Soldevilla B; Cuevas-Martín C; Ibáñez C; Santacatterina F; Alberti MA; Simó C; Casasnovas C; Márquez-Infante C; Sevilla T; Pascual SI; Sánchez-Aragó M; Espinos C; Palau F; Cuezva JM
    PLoS One; 2017; 12(6):e0178376. PubMed ID: 28575008
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of gait patterns and functional measures between Charcot-Marie-Tooth disease type I and II in children to young adults.
    Pogemiller K; Garibay E; Pierz K; Acsadi G; Õunpuu S
    Gait Posture; 2020 Mar; 77():236-242. PubMed ID: 32062403
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Augmenting Clinical Outcome Measures of Gait and Balance with a Single Inertial Sensor in Age-Ranged Healthy Adults.
    O'Brien MK; Hidalgo-Araya MD; Mummidisetty CK; Vallery H; Ghaffari R; Rogers JA; Lieber R; Jayaraman A
    Sensors (Basel); 2019 Oct; 19(20):. PubMed ID: 31635375
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development and validation of the Charcot-Marie-Tooth Disease Infant Scale.
    Mandarakas MR; Menezes MP; Rose KJ; Shy R; Eichinger K; Foscan M; Estilow T; Kennedy R; Herbert K; Bray P; Refshauge K; Ryan MM; Yiu EM; Farrar M; Sampaio H; Moroni I; Pagliano E; Pareyson D; Yum SW; Herrmann DN; Acsadi G; Shy ME; Burns J; Sanmaneechai O
    Brain; 2018 Dec; 141(12):3319-3330. PubMed ID: 30476010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.